PUBLIC COMPANY
saveAccutar Biotechnology Inc
updated 2mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- phase1Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
- phase1A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
- phase1A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer
- phase1A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
- phase1A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that